Phase 3 enrolment of clinical trials for COVISHIELD vaccine completed

Mid-Day

12 Nov 2020 0 shares 1 views

Phase 3 enrolment of clinical trials for COVISHIELD vaccine completed

Phase 3 enrolment of clinical trials for COVISHIELD vaccine completed

Mid-Day

Published 12 Nov 2020

The Serum Institute of India (SII) and the Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment for Phase 3 clinical trials for coronavirus vaccine COVISHIELD in India.

SII, the world's largest vaccine manufacturer by volume, and ICMR, the apex body in India for biomedical research, have...

You might like

Related news coverage

Volunteer seeks investigation on Serum after developing complication but company is intimidating

Mid-Day 30 Nov 2020

The 40-year old volunteer, who works as a business consultant had wanted to investigate the cause of him contracting severe..

Centre to electronically track details of COVID-19 vaccine recipients: Harsh Vardhan
Mid-Day 20 Nov 2020
Centre to electronically track details of COVID-19 vaccine recipients: Health Minister
Mid-Day 19 Nov 2020
COVISHIELD completes enrolment of Phase III clinical trials under ICMR, SII's partnership
newKerala.com 12 Nov 2020
Enrolment for Phase III clinical trials of COVISHIELD vaccine completed
newKerala.com 12 Nov 2020

Advertisement

More coverage

India needs 1.7 billion COVID-19 vaccine doses for adult population

Mid-Day 12 Nov 2020

The key vaccines India is banking on are from Oxford/AstraZeneca, Novavax and J&J and the earliest efficacy data is expected by the..

COVISHIELD completes enrolment of Phase-3 clinical trials under partnership of ICMR and Serum Institute of India
Hindu 12 Nov 2020
Which Covid vaccine candidates are competing against Pfizer?
Proactive Investors 10 Nov 2020
Who is competing against Pfizer COVID-19 vaccine candidate?
Proactive Investors 10 Nov 2020
Which Covid vaccine candidates are competing against Pfizer ?
Proactive Investors 10 Nov 2020